BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12369950)

  • 1. P2-pyrimidinergic receptors and their ligands.
    Müller CE
    Curr Pharm Des; 2002; 8(26):2353-69. PubMed ID: 12369950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2 receptors activated by uracil nucleotides--an update.
    Brunschweiger A; Müller CE
    Curr Med Chem; 2006; 13(3):289-312. PubMed ID: 16475938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.
    Jacobson KA; Costanzi S; Ohno M; Joshi BV; Besada P; Xu B; Tchilibon S
    Curr Top Med Chem; 2004; 4(8):805-19. PubMed ID: 15078212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of several types of metabotropic nucleotide receptors in single cerebellar astrocytes.
    Jiménez AI; Castro E; Communi D; Boeynaems JM; Delicado EG; Miras-Portugal MT
    J Neurochem; 2000 Nov; 75(5):2071-9. PubMed ID: 11032896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple P2Y receptors couple to calcium-dependent, chloride channels in smooth muscle cells of the rat pulmonary artery.
    Chootip K; Gurney AM; Kennedy C
    Respir Res; 2005 Oct; 6(1):124. PubMed ID: 16250909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta.
    Guns PJ; Korda A; Crauwels HM; Van Assche T; Robaye B; Boeynaems JM; Bult H
    Br J Pharmacol; 2005 Sep; 146(2):288-95. PubMed ID: 15997227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tools and drugs for uracil nucleotide-activated P2Y receptors.
    Rafehi M; Müller CE
    Pharmacol Ther; 2018 Oct; 190():24-80. PubMed ID: 29660366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration.
    Pillois X; Chaulet H; Belloc I; Dupuch F; Desgranges C; Gadeau AP
    Circ Res; 2002 Apr; 90(6):678-81. PubMed ID: 11934835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
    von Kügelgen I
    Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed.
    Buvinic S; Briones R; Huidobro-Toro JP
    Br J Pharmacol; 2002 Jul; 136(6):847-56. PubMed ID: 12110609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
    Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
    Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2Y receptors: focus on structural, pharmacological and functional aspects in the brain.
    Fischer W; Krügel U
    Curr Med Chem; 2007; 14(23):2429-55. PubMed ID: 17979698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide.
    Warny M; Aboudola S; Robson SC; Sévigny J; Communi D; Soltoff SP; Kelly CP
    J Biol Chem; 2001 Jul; 276(28):26051-6. PubMed ID: 11349132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of contractile P2Y1, P2Y6, and P2Y12 receptors in rat intrapulmonary artery using selective ligands.
    Mitchell C; Syed NI; Tengah A; Gurney AM; Kennedy C
    J Pharmacol Exp Ther; 2012 Dec; 343(3):755-62. PubMed ID: 22991416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UDP is a competitive antagonist at the human P2Y14 receptor.
    Fricks IP; Maddileti S; Carter RL; Lazarowski ER; Nicholas RA; Jacobson KA; Harden TK
    J Pharmacol Exp Ther; 2008 May; 325(2):588-94. PubMed ID: 18252808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
    Maruoka H; Barrett MO; Ko H; Tosh DK; Melman A; Burianek LE; Balasubramanian R; Berk B; Costanzi S; Harden TK; Jacobson KA
    J Med Chem; 2010 Jun; 53(11):4488-501. PubMed ID: 20446735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ecto-NTPDases on UDP-sensitive P2Y(6) receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women.
    Noronha-Matos JB; Costa MA; Magalhães-Cardoso MT; Ferreirinha F; Pelletier J; Freitas R; Neves JM; Sévigny J; Correia-de-Sá P
    J Cell Physiol; 2012 Jun; 227(6):2694-709. PubMed ID: 21898410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
    Yu Y; Zhang C
    Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y nucleotide receptors: promise of therapeutic applications.
    Jacobson KA; Boeynaems JM
    Drug Discov Today; 2010 Jul; 15(13-14):570-8. PubMed ID: 20594935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.